F.D.A. Grants Full Approval to Pfizer COVID-19 Vaccine

The Food and Drug Administration has reportedly granted full approval to the

Pfizer-BioNTech coronavirus vaccine. The vaccine has been approved for

people 16 years of age and older, which makes the vaccine the first one to go

past the emergency use status granted to Moderna and previously—Johnson &


FDA commissioner Janet Woodcock spoke on the full approval, saying, “The

public can be very confident that this vaccine meets the high standards for

safety, effectiveness and manufacturing quality the FDA requires of an

approved product.

The CEO of Pfizer—Albert Bourla, said he hopes the move by the FDA “will

help increase confidence in our vaccine, as vaccination remains the best tool

we have to help protect lives.” Reports noted the shot will now go by the name

Comirnaty in the United States. As of now, over half of the United States

population has been fully vaccinated with one of the three vaccine options

from Johnson & Johnson, Moderna, or Pfizer.  Stay tuned for more updates.

source: Associated Press

Related posts

Leave a Comment